FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marcus Schuchmann

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Living Beings

Concepts & Ideas

Physiology

Signal Transduction

Co-author Network

Publications

TOP 3
Marcus A Wörns; Peter R Galle; Thomas Gamstätter; Sandra Koch; Jens U Marquardt; Marc Nguyen-Tat; Ina M Niederle; Marcus Schuchmann; Henning Schulze-Bergkamen; Arndt Weinmann
The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib.
Anja Lautem; Gerd Otto; Arno Schad; Jörn M Schattenberg; Marcus Schuchmann; Nina Weiler; Anca Zimmermann; Daniel Foltys; Peter R Galle; Andreas Gräsel; Michael Heise; Maria Hoppe-Lotichius; Johanna Knapstein; Hauke Lang; Tim Zimmermann
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Marcus Schuchmann; Martin F Sprinzl; Christian Trautwein; Daniel Wachtlin; Stefan Zeuzem; Tim Zimmermann; Thomas Berg; Wulf O Böcher; Anne Ehrlich; Christoph Eisenbach; Roger Gösseringer; Rainer Günther; Jens M Kittner; Dietmar M Klass; Konrad Neumann; Jörg F Schlaak; Peter R Galle
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marcus Schuchmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marcus A Wörns; Peter R Galle; Thomas Gamstätter; Sandra Koch; Jens U Marquardt; Marc Nguyen-Tat; Ina M Niederle; Marcus Schuchmann; Henning Schulze-Bergkamen; Arndt Weinmann
The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013;45(5):408-13.
2013: Anja Lautem; Gerd Otto; Arno Schad; Jörn M Schattenberg; Marcus Schuchmann; Nina Weiler; Anca Zimmermann; Daniel Foltys; Peter R Galle; Andreas Gräsel; Michael Heise; Maria Hoppe-Lotichius; Johanna Knapstein; Hauke Lang; Tim Zimmermann
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
International journal of oncology 2013;42(4):1297-304.
2013: Marcus Schuchmann; Martin F Sprinzl; Christian Trautwein; Daniel Wachtlin; Stefan Zeuzem; Tim Zimmermann; Thomas Berg; Wulf O Böcher; Anne Ehrlich; Christoph Eisenbach; Roger Gösseringer; Rainer Günther; Jens M Kittner; Dietmar M Klass; Konrad Neumann; Jörg F Schlaak; Peter R Galle
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013;45(4):323-9.
2013: Martin F Sprinzl; Hanna Tönissen; Arndt Weinmann; Tim Zimmermann; Peter R Galle; Torsten Hansen; Maria Hoppe-Lotichius; Sandra Koch; Nikola Lohse; Gerd Otto; Jörn M Schattenberg; Marcus Schuchmann
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2013;26(1):67-74.
2012: Toni Urbanik; Ari Waisman; Marcus A Wörns; Katharina Becker; Regina Johanna Boger; Karl Roland Ehrenberg; Matthias Hahn; Nadine Hövelmeyer; Dirk Jäger; Thomas Longerich; Marcus Schuchmann; Henning Schulze-Bergkamen
Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.
Journal of hepatology 2012;57(5):995-1003.
2012: Ina M Niederle; Gerd Otto; Marcus Schuchmann; Christoph Düber; Peter R Galle; Sandra Koch; Marc Nguyen-Tat; Marcus A Wörns; Arndt Weinmann
Clinicopathologic features and prognosis of young patients with hepatocellular carcinoma in a large German cohort.
Journal of clinical gastroenterology 2012;46(9):775-8.
2012: M Nguyen-tat; Simin Schadmand-Fischer; Marcus Schuchmann; E Siegel; P R Galle; T Gamstätter; E Geißinger; H Lang; J U Marquardt; Marcus A Wörns
IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma.
Zeitschrift für Gastroenterologie 2012;50(9):1008-12.
2012: Jörn M Schattenberg; Detlef Schuppan; Marcus A Wörns; Tim Zimmermann; Peter R Galle; You-Wen He; Yong Ook Kim; Tobias Kohl; Thomas Longerich; Michael Nagel; Arno Schad; Marcus Schuchmann
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
American journal of physiology. Gastrointestinal and liver physiology 2012;303(4):G498-506.
2012: Torsten Hansen; Michael Heise; David Hollemann; Maria Hoppe-Lotichius; C James Kirkpatrick; Michael B Pitton; Marcus Schuchmann; Gerd Otto
Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation--a morphological clue to ischemic-type biliary lesion?
Virchows Archiv : an international journal of pathology 2012;461(1):41-8.
2012: Dominique Larrey; Ansgar W Lohse; Martin Marquis; Philippe Mathurin; Joseph Scherer; Marcus Schuchmann; Jerry O Stern; Robert Thimme; Albert Tran; Christian Trautwein; Christian Trepo; Katherine Wu; Jean-Pierre Zarski; Nasri Abdallah; Keikawus Arastéh; Frank Berger; Wulf O Böcher; Andreas Cerny; Victor de Ledinghen; Nektarios Dikopoulos; Guido Gerken; Tilman Gerlach; Birgit Girlich; Markus H Heim; George Kukolj; Jürgen Steffgen
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin.
Journal of hepatology 2012;57(1):39-46.
2012: Marcus A Wörns; Michael B Pitton; Marcus Schuchmann; Anja Victor; Arndt Weinmann; Timon Bosslet; Christoph Düber; Peter R Galle; Torsten Hansen; Michael Heise; Maria Hoppe-Lotichius; Sandra Koch; Ina M Niederle; Gerd Otto
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.
Scandinavian journal of gastroenterology 2012;47(6):718-28.
2012: Jörn M Schattenberg; Peter R Galle; You-Wen He; Marcus A Wörns; Tim Zimmermann; Marcus Schuchmann
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.
Free radical biology & medicine 2012;52(9):1911-7.
2012: Jens M Kittner; Jörn M Schattenberg; Peter R Galle; Annette Grambihler; Martin F Sprinzl; Arndt Weinmann; Marcus Schuchmann
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2012;54(1):93-5.
2012: Arndt Weinmann; Christoph Düber; Peter Robert Galle; Michael Heise; Maria Hoppe-Lotichius; Sandra Koch; Ina Maria Niederle; Gerd Otto; Marcus Schuchmann; Marcus A Wörns
Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012;44(5):432-7.
2012: Michael Heise; Maria Hoppe-Lotichius; Johanna Knapstein; Anja Lautem; Gerd Otto; Arno Schad; Jörn M Schattenberg; Marcus Schuchmann; Nina Weiler; Anca Zimmermann; Daniel Foltys; Peter R Galle; Dirk Gründemann; Tim Zimmermann
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
BMC cancer 2012;12():109.
2011: Jörn M Schattenberg; Henning Schulze Bergkamen; Peter R Galle; You-Wen He; Tobias Kohl; Andreas Kreft; Michael Nagel; Juergen Siebler; Martin F Sprinzl; Marcus A Wörns; Tim Zimmermann; Marcus Schuchmann
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
Journal of hepatology 2011;55(6):1272-80.
2011: Tim Zimmermann; Norbert Weiler; Stefan Biesterfeld; Daniel Foltys; Peter R Galle; Michael Heise; Maria Hoppe-Lotichius; Andreas Körner; Anja Lautem; Gerd Otto; Irene Schmidtmann; Marcus Schuchmann
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2011;24(11):1059-67.
2011: Martin Goetz; Jacqueline V Ansems; Peter R Galle; Marcus Schuchmann; Ralf Kiesslich
In vivo real-time imaging of the liver with confocal endomicroscopy permits visualization of the temporospatial patterns of hepatocyte apoptosis.
American journal of physiology. Gastrointestinal and liver physiology 2011;301(5):G764-72.
2011: Anca Zimmermann; Tim Zimmermann; Jörn M Schattenberg; Sebastian Pöttgen; Johannes Lotz; Heidi Rossmann; Ralf Roeddiger; Stefan Biesterfeld; Hans-Christian Geiss; Marcus Schuchmann; Peter R Galle; Matthias M Weber
Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome.
European journal of internal medicine 2011;22(3):305-10.
2011: Gerd Otto; Maria Hoppe-Lotichius; Fernando Bittinger; Marcus Schuchmann; C Düber
Klatskin tumour: meticulous preoperative work-up and resection rate.
Zeitschrift für Gastroenterologie 2011;49(4):436-42.
2011: J W Rey; O Schreiner; Ana P Barreiros; M Heise; M Krupp; Marcus Schuchmann; Gerd Otto; Peter Galle; Andreas Teufel
Acute renal failure and liver dysfunction after subcutaneous injection of 3-sn-phosphatidylcholine (Lipostabil®)-case report.
Zeitschrift für Gastroenterologie 2011;49(3):340-3.
2011: Christina Hartmann; Marcus Schuchmann; Tim Zimmermann
Posttransplant lymphoproliferative disease in liver transplant patients.
Current infectious disease reports 2011;13(1):53-9.
2011: Arthur Hoffman; Fareed Rahman; Sarah Prengel; Marcus Schuchmann; Martin Gotz; Markus Moehler; Peter Robert Galle; Zhiping Li; Anthony N Kalloo; Ralf Kiesslich
Mini-laparoscopy in the endoscopy unit: Safety and outcomes in over one thousand patients.
World journal of gastrointestinal endoscopy 2011;3(1):6-10.
2011: Thomas Gamstätter; Ina M Niederle; Simin Schadmand-Fischer; Marcus Schuchmann; Pia R Spies; Arndt Weinmann; Peter R Galle; Marcus-Alexander Wörns
AFP measurement in monitoring treatment response of advanced hepatocellular carcinoma to sorafenib: case report and review of the literature.
Onkologie 2011;34(10):538-42.
2011: Jörn M Schattenberg; Marcus Schuchmann; Peter Robert Galle
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
Journal of gastroenterology and hepatology 2011;26 Suppl 1():213-9.
2011: Toni Urbanik; Bruno Christian Köhler; Regina Johanna Boger; Marcus A Wörns; Steffen Heeger; Gerd Otto; Nadine Hövelmeyer; Peter Robert Galle; Marcus Schuchmann; Ari Waisman; Henning Schulze-Bergkamen
Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
International journal of oncology 2011;38(1):121-31.
2010: Tim Zimmermann; Maria Hoppe-Lotichius; Vuk Tripkovic; Ana P Barreiros; Thomas C Wehler; Anca Zimmermann; Jörn M Schattenberg; Michael Heise; Stefan Biesterfeld; Peter R Galle; Gerd Otto; Marcus Schuchmann
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
European journal of internal medicine 2010;21(3):208-15.
2010: Marcus A Wörns; Marcus Schuchmann; Christoph Düber; Gerd Otto; Peter Robert Galle; Arndt Weinmann
Sunitinib in patients with advanced hepatocellular carcinoma after progression under sorafenib treatment.
Oncology 2010;79(1-2):85-92.
2009: Bruno-Christian Koehler; Toni Urbanik; Binje Vick; Regina-Johanna Boger; Steffen Heeger; Peter-R Galle; Marcus Schuchmann; Henning Schulze-Bergkamen
TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
World journal of gastroenterology : WJG 2009;15(47):5924-35.
2009: Jörn M Schattenberg; Marcus Schuchmann
Shortcut to death.
Hepatology (Baltimore, Md.) 2009;50(6):2040-3.
2009: Jörn M Schattenberg; Marcus Schuchmann
Diabetes and apoptosis: liver.
Apoptosis : an international journal on programmed cell death 2009;14(12):1459-71.
2009: T Zimmermann; C Otto; Maria Hoppe-Lotichius; Stefan Biesterfeld; A Lautem; M Knaak; A Zimmermann; Ana P Barreiros; M Heise; Jörn M Schattenberg; Martin F Sprinzl; Peter Galle; Gerd Otto; Marcus Schuchmann
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
Transplantation proceedings 2009;41(6):2549-56.
2009: Marcus Alexander Wörns; Arndt Weinmann; Kerstin Pfingst; Carla Schulte-Sasse; Claudia M Messow; Henning Schulze-Bergkamen; Andreas Teufel; Marcus Schuchmann; Stephan Kanzler; Christoph Düber; Gerd Otto; Peter Robert Galle
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
Journal of clinical gastroenterology 2009;43(5):489-95.
2009: Binje Vick; Achim Weber; Toni Urbanik; Thorsten Maass; Andreas Teufel; Peter H Krammer; Joseph T Opferman; Marcus Schuchmann; Peter R Galle; Henning Schulze-Bergkamen
Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes.
Hepatology (Baltimore, Md.) 2009;49(2):627-36.
2009: Marcus Alexander Wörns; Arndt Weinmann; Marcus Schuchmann; Peter Robert Galle
Systemic therapies in hepatocellular carcinoma.
Digestive diseases (Basel, Switzerland) 2009;27(2):175-88.
2008: Marcus Schuchmann; Ralf G Meyer; E Distler; Esther Von Stebut; Jürgen Kuball; Elke Schnürer; T Wölfel; M Theobald; Abdo Konur; S Gregor; O Schreiner; Christoph Huber; Peter R Galle; Gerd Otto; Wolfgang Herr
The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(11):2434-44.
2008: Sascha Herber; Stefan Biesterfeld; U Franz; J Schneider; Jochen Thies; Marcus Schuchmann; Christoph Düber; Michael B Pitton; Gerd Otto
Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
Cardiovascular and interventional radiology 2008;31(4):768-77.
2008: Sascha Herber; Gerd Otto; J Schneider; Marcus Schuchmann; Christoph Düber; Michael B Pitton; I Kummer; N Manzl
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
AJR. American journal of roentgenology 2008;190(4):1035-42.
2008: Juergen Siebler; Stefan Wirtz; Christian Frenzel; Marcus Schuchmann; Ansgar W Lohse; Peter R Galle; Markus F Neurath
Cutting edge: a key pathogenic role of IL-27 in T cell- mediated hepatitis.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(1):30-3.
2007: Juergen Siebler; Marcus Schuchmann; Susanne Strand; Hans-Anton Lehr; Markus F Neurath; Peter R Galle
Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.
Digestive diseases and sciences 2007;52(9):2396-402.
2007: Sascha Herber; Michael B Pitton; Christian Mönch; J Schneider; N Manzl; I Kummer; Stephan Kanzler; Marcus Schuchmann; Theodor Junginger; Christoph Düber; Gerd Otto
[Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Zentralblatt für Chirurgie 2007;132(4):306-15.
2007: Tim Zimmermann; Wulf O Böcher; Stefan Biesterfeld; Anca Zimmermann; Stephan Kanzler; Gertrud Greif-Higer; Ana P Barreiros; Martin F Sprinzl; Marcus A Wörns; Ansgar W Lohse; Christian Mönch; Gerd Otto; Peter R Galle; Marcus Schuchmann
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(7):583-90.
2007: Christian Moench; Ana P Barreiros; Marcus Schuchmann; Fernando Bittinger; J Thiesen; G Hommel; I Kraemer; Gerd Otto
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(6):1616-23.
2007: Tehila Ben Moshe; Hila Barash; kang tae-bong; Jin-Chul Kim; Andrew Kovalenko; Eitan Gross; Marcus Schuchmann; Rinat Abramovitch; Eithan Galun; David Wallach
Role of caspase-8 in hepatocyte response to infection and injury in mice.
Hepatology (Baltimore, Md.) 2007;45(4):1014-24.
2007: Gerd Otto; M Heise; Christian Moench; Sascha Herber; Fernando Bittinger; Marcus Schuchmann; Maria Hoppe-Lotichius; Michael B Pitton
Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
Transplantation proceedings 2007;39(2):537-9.
2007: Sascha Herber; Gerd Otto; M Woerns; Christian Moench; Stephan Kanzler; Theodor Junginger; J Schneider; Marcus Schuchmann; I Kummer; N Manzl; Christoph Düber; Michael B Pitton
[Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2007;179(3):289-99.
2006: Jörn M Schattenberg; Peter R Galle; Marcus Schuchmann
[Acute liver failure--medical viewpoints].
Praxis 2006;95(48):1873-7.
2006: Jörn M Schattenberg; Peter R Galle; Marcus Schuchmann
Apoptosis in liver disease.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(8):904-11.
2006: Gerd Otto; Sascha Herber; Michael Heise; Ansgar W Lohse; Christian Mönch; Fernando Bittinger; Maria Hoppe-Lotichius; Marcus Schuchmann; Anja Victor; Michael B Pitton
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(8):1260-7.
2006: Tim Zimmermann; Giancarlo Maccagno; Peter Galle; Gerd Otto; Walter E Hitzler; Marcus Schuchmann
Alloimmune hemolytic anemia after liver transplantation from an ABO-identical and Rh-nonidentical donor in a patient with postpartum Budd-Chiari syndrome.
Transplant international : official journal of the European Society for Organ Transplantation 2006;19(6):514-5.
2006: Henning Schulze-Bergkamen; Marcus Schuchmann; Binje Fleischer; Peter R Galle
The role of apoptosis versus oncotic necrosis in liver injury: facts or faith?
Journal of hepatology 2006;44(5):984-93.
2006: Wulf O Böcher; Marcus Schuchmann; Ralph Link; Heribert Hillenbrand; Fareed Rahman; Martin F Sprinzl; Jonas Mudter; Hanns F Löhr; Peter R Galle
Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(3):319-25.
2006: Juergen Siebler; Ulrike Protzer; Stefan Wirtz; Marcus Schuchmann; Thomas Höhler; Peter R Galle; Markus F Neurath
Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication.
European journal of gastroenterology & hepatology 2006;18(2):167-74.
2006: Martin F Sprinzl; Gerd Otto; Peter R Galle; Marcus Schuchmann
Hepatitis C virus re-infection: new perspectives.
Clinical transplantation 2006;20 Suppl 17():117-23.
2006: Henning Schulze-Bergkamen; Binje Fleischer; Marcus Schuchmann; Achim Weber; Arndt Weinmann; Peter H Krammer; Peter R Galle
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
BMC cancer 2006;6():232.
2006: Marcus Schuchmann; Henning Schulze-Bergkamen; Binje Fleischer; Jörn M Schattenberg; Juergen Siebler; Arndt Weinmann; Andreas Teufel; Marcus A Wörns; Thomas Fischer; Susanne Strand; Ansgar W Lohse; Peter R Galle
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.
Oncology reports 2006;15(1):227-30.
2006: Binje Fleischer; Henning Schulze-Bergkamen; Marcus Schuchmann; Achim Weber; Stefan Biesterfeld; Martina Müller; Peter H Krammer; Peter R Galle
Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
International journal of oncology 2006;28(1):25-32.
2005: Marcus Schuchmann; Felix Ruckert; Jose Francisco Garcia-Lazaro; Andrea Karg; Jürgen Burg; Natalia Knorr; Juergen Siebler; Eugene E Varfolomeev; David Wallach; Wolfgang Schreiber; Ansgar W Lohse; Peter R Galle
MORT1/FADD is involved in liver regeneration.
World journal of gastroenterology : WJG 2005;11(46):7248-53.
2005: Johannes Herkel; Marcus Schuchmann; Gisa Tiegs; Ansgar W Lohse
Immune-mediated liver injury.
Journal of hepatology 2005;42(6):920-3.
2004: Jürgen Kuball; Matthias Theobald; Edite Antunes Ferreira; Georg Hess; Jürgen Burg; Giancarlo Maccagno; Ana P Barreiros; Stefan Lüth; Carl C Schimanski; Marcus Schuchmann; Andreas Schwarting; Markus F Neurath; Gerd Otto; Peter R Galle; Ansgar W Lohse
Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions.
Transplantation 2004;78(12):1774-9.
2004: Marcus Schuchmann; Frank Hermann; Johannes Herkel; Ruurd van der Zee; Peter R Galle; Ansgar W Lohse
HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells.
Immunology letters 2004;93(2-3):199-204.
2003: Jian Xu; Rudolf Lucas; Marcus Schuchmann; Simone Kühnle; Thomas Meergans; Ana P Barreiros; Ansgar W Lohse; Gerd Otto; Jian Xu
GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(2):938-47.
2003: Marcus Schuchmann; Eugene E Varfolomeev; Frank Hermann; Felix Rueckert; Dennis Strand; Heinz H Koehler; Susanne Strand; Ansgar W Lohse; David Wallach; Peter R Galle
Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure.
Hepatology (Baltimore, Md.) 2003;37(1):129-35.
2002: Marcus Schuchmann; Peter R Galle; Stephan Kanzler
[Apoptosis in disease].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(12):738-46.
2002: Martin H Holtmann; Marcus Schuchmann; Geraldine Zeller; Peter R Galle; Markus F Neurath
The emerging distinct role of TNF-receptor 2 (p80) signaling in chronic inflammatory disorders.
Archivum immunologiae et therapiae experimentalis 2002;50(4):279-88.
2001: Marcus Schuchmann; Peter R Galle
Apoptosis in liver disease.
European journal of gastroenterology & hepatology 2001;13(7):785-90.
1998: Eugene E Varfolomeev; Marcus Schuchmann; V Luria; N Chiannilkulchai; Jacques Beckmann; I L Mett; D Rebrikov; V M Brodianski; O C Kemper; Orit Kollet; Tsvee Lapidot; D Soffer; Tama Sobe; Karen B Avraham; Tanya M Goncharov; Helmut Holtmann; Peter Lonai; David Wallach
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.
Immunity 1998;9(2):267-76.